| Ytd | -40.86% | |
| 1y | 59.68% |
| Open | 0.79 | Prev Close | 0.78 | Low | 0.77 | High | 0.80 | Mkt Cap | 52.15M |
| Vol | 193.67K | Avg Vol | 947.13K | EPS | -0.41 | P/E | -1.95 | Forward P/E | -1.41 |
| Beta | 0.78 | Short Ratio | 0.36 | Inst. Own | 19.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.78 | 200-d Avg | 1.19 | 1yr Est | 11.50 |
RANI News
SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI),
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday'
SAN JOSE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeu
RT-114 achieved systemic exposure greater than 150% relative to a matched 12mg subcutaneous dose of
RT-114 achieved systemic exposure greater than 150% relative to a matched 12mg subcutaneous dose of
~ Collaboration will leverage the RaniPill® platform to explore oral delivery of PegBio's proprietar
SAN JOSE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeu
SAN JOSE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeut
- Continued advancement of the ongoing Phase 1 study of RT-114 via RaniPill® for the treatment of ob
SAN JOSE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeut
SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therape
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript
- Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-valu
SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therape
Rani Therapeutics (NASDAQ: RANI - Get Free Report) and Milestone Pharmaceuticals (NASDAQ: MIST - Get
SAN JOSE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therape
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI - Get Free Report) has earned an average recommendati
SAN JOSE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeu
- A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight lo
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI - Get Free Report)'s share price fell 2.2% during mid
SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeu
– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-valu
Biotech stocks have trailed the broader market this year, but more names are starting to show streng
On Tuesday, 647 companies set new 52-week lows.
Friday's session saw 225 companies set new 52-week lows.
Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earni
On Tuesday, 120 companies set new 52-week lows.
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media S
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Th